Get it on Google Play

Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth | Direct Line March 2026 (Free)

Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth | Direct Line March 2026 (Free)

Author: Barbell Medicine March 24, 2026 Duration: 30:34
Barbell Medicine Podcast
HealthHealth & FitnessFitness

In this free preview of the March 2026 Direct Line AMA. Drs. Feigenbaum and Baraki cover: VO2 max versus cardiorespiratory fitness for longevity (are Peter Attia’s targets evidence-based? — with Goodhart’s Law and the JAMA evidence), what GLP-1 medications actually cost now via manufacturer programs ($149–449/month), and whether 7,000–10,000 daily steps actually meet the bar for cardiovascular training.


Full episode for Barbell Medicine Plus subscribers at https://barbellmedicine.supercast.com/


Timestamps:

0:00 — Introduction

3:26 — VO2 Max vs. Cardiorespiratory Fitness for Longevity

14:11 — GLP-1 Costs: What you should actually be paying now

21:43 — Is Walking Enough for Cardiovascular Health?


Next Steps:


For evidence-based resistance training programs: barbellmedicine.com/training-programs


For individualized training consultation: barbellmedicine.com/coaching


Explore our full library of articles on health and performance: barbellmedicine.com/resources


To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com


Resources:


  • JAMA Network Open — Cardiorespiratory Fitness & Long-term Mortality (Mandsager et al.) — Exercise capacity (METs) and longevity — the foundational CRF/mortality study cited in the episode https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428
  • JAMA — Blair et al. — Physical fitness and all-cause mortality: a prospective study of healthy men and women https://jamanetwork.com/journals/jama/fullarticle/379243
  • Barbell Medicine Vital Five — Multi-modal CRF benchmarks and longevity targets https://www.barbellmedicine.com/vital-5-action-plan/
  • Lilly Direct — Zepbound (tirzepatide) — Manufacturer direct program ($299–449/month) https://www.lillydirect.com/zepbound
  • NovoCare — Wegovy (semaglutide) — Manufacturer savings program ($149–349/month) https://www.novocare.com/patient/medicines/wegovy.html
  • Orforglipron — Eli Lilly oral GLP-1 — What to know about orforglipron (small-molecule oral GLP-1 agonist, pending FDA approval) https://www.lilly.com/news/stories/what-to-know-about-orforglipron


Our Sponsors:
* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com
* Check out Factor and use my code factormeals.com/bbm50off for a great deal: https://www.factor75.com
* Check out Quince and use my code quince.com/BBM for a great deal: https://www.quince.com


Advertising Inquiries: https://redcircle.com/brands

Hosted by the team at Barbell Medicine, the Barbell Medicine Podcast delves into the complex intersection of health, fitness, and medical science. Rather than offering quick fixes, the discussions here are grounded in evidence-based practice, exploring how training, nutrition, and lifestyle intersect with long-term well-being. You’ll hear nuanced conversations that challenge common fitness myths and provide practical insights applicable to both everyday lifters and clinical populations. Episodes often feature deep dives into rehabilitation, strength programming, pain science, and metabolic health, all delivered with a focus on applying robust scientific principles to real-world scenarios. This podcast serves as a valuable resource for anyone looking to move beyond oversimplified advice and understand the “why” behind effective training and sustainable health practices. Tune in for thoughtful analysis and accessible explanations that make the latest research relevant to your own goals.
Author: Language: English Episodes: 50

Official website RSS
Barbell Medicine Podcast
Podcast Episodes
Is Obesity A Muscle Problem? [not-audio_url] [/not-audio_url]

Duration: 1:17:06
Muscle is where most of the glucose goes, and muscle insulin resistance is the first thing that breaks on the road to type 2 diabetes. Both of those are true, and neither one means that building more muscle is the treatm…
Who Needs Testosterone, and Who's Not Getting It I Signal Episode 4 [not-audio_url] [/not-audio_url]

Duration: 1:26:41
Most men who start testosterone never needed it, and some who genuinely do never get treated. In the final episode of the Signal series, Dr. Jordan Feigenbaum and Dr. Austin Baraki work through who actually needs testost…
Your Fat Has a Storage Limit [not-audio_url] [/not-audio_url]

Duration: 49:19
In 2004 a surgeon removed about ten kilograms of fat from fifteen women and measured everything that mattered. Nothing improved. Four years later, it still hadn't.That result should have ended an argument about body fat.…
The FDA Voted for 6 Peptides. Its Own Scientists Said No [not-audio_url] [/not-audio_url]

Duration: 1:06:20
An FDA advisory committee just voted to open a legal compounding supply line for six of seven peptides, including BPC-157 and TB-500, over the objection of the FDA's own scientists, who recommended against all seven. Dr.…
The Man Who Couldn’t Stop Gaining Weight | A Medical Mystery [not-audio_url] [/not-audio_url]

Duration: 1:10:08
A previously healthy 21-year-old shows up with seven months of headaches and 30-plus pounds of weight gain he can’t explain. He’s eating the same and training more, and the scale climbs anyway. We hand the case to Dr. Au…

12345»